Application Sponsors
ANDA 203379 | CADILA PHARMS LTD | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET;ORAL | 1.25MG | 0 | GLYBURIDE | GLYBURIDE |
002 | TABLET;ORAL | 2.5MG | 0 | GLYBURIDE | GLYBURIDE |
003 | TABLET;ORAL | 5MG | 0 | GLYBURIDE | GLYBURIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-01-04 | |
Submissions Property Types
TE Codes
001 | Prescription | AB1 |
002 | Prescription | AB1 |
003 | Prescription | AB1 |
CDER Filings
CADILA PHARMS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 203379
[companyName] => CADILA PHARMS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"GLYBURIDE","activeIngredients":"GLYBURIDE","strength":"1.25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"GLYBURIDE","activeIngredients":"GLYBURIDE","strength":"2.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"GLYBURIDE","activeIngredients":"GLYBURIDE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"01\/04\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-01-04
)
)